Akciový screener zdarma
Load Uložit Seznam sledování Help| Symbol | Společnost | Burza | Odvětví | Tržní kapitalizace | EBITDA | P/E | EV / EBITDA | Dluh/Vlastní kapitál | Průměrný objem | Institucionální vlastnictví | Hospodářské výsledky | Cena | Dnešní výkon |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Pharmaceuticals | $459.47B | $32.631B | 10.82 | 14.31 | 1.44 | 9.493M | 70.32% | 15 Oct 2024 | $164.82 | -1.53% |
| LLY | Lilly(Eli) & Co | NYSE | Pharmaceuticals | $343.00B | $15.041B | 112.99 | 61.85 | 4.93 | N/A | 84.30% | 30 Oct 2024 | $920.89 | +2.18% |
| PFE | Pfizer Inc. | NYSE | Pharmaceuticals | $291.64B | $39.014B | N/A | 5.57 | 1.54 | 5.921M | 69.08% | 29 Oct 2024 | $29.66 | -0.27% |
| ABBV | Abbvie Inc | NYSE | Pharmaceuticals | $288.27B | $22.237B | 64.86 | 18.20 | 12.00 | N/A | 71.44% | 25 Oct 2024 | $194.59 | -2.39% |
| RHHBY | Roche Holding AG | OTC | Pharmaceuticals | $280.28B | CHF23.955B | 23.57 | 11.78 | 2.61 | 1.981M | 1.27% | N/A | $37.33 | -5.99% |
| RHHVF | Roche Holding AG | OTC | Pharmaceuticals | $278.66B | CHF23.955B | 25.25 | 11.57 | 1.72 | 9.306k | 38.17% | N/A | $316.22 | +5.69% |
| MRK | Merck & Co Inc | NYSE | Pharmaceuticals | $276.92B | $20.142B | 21.20 | 15.90 | 1.84 | N/A | 75.30% | 31 Oct 2024 | $114.71 | -0.54% |
| MRK | Merck & Co., Inc. | EURONEXT | Pharmaceuticals | $273.78B | $24.074B | 19.93 | 12.15 | 1.83 | 0.000 | 76.35% | N/A | €101.40 | +0.00% |
| AZN | AstraZeneca Plc | LSE | Pharmaceuticals | $215.98B | $12.522B | 33.54 | 17.49 | 1.58 | 1.543M | 49.18% | N/A | GBX12,202.00 | -0.86% |
| AZN | Astrazeneca plc | NYSE | Pharmaceuticals | $215.24B | $12.929B | 98.21 | 22.56 | 1.58 | N/A | 17.84% | 12 Nov 2024 | $80.53 | -0.78% |
| ZEG | AstraZeneca Plc | XETRA | Pharmaceuticals | $210.39B | 12.522B$ | 57.94 | 18.39 | 1.68 | 9.087k | 47.18% | N/A | €144.80 | -0.58% |
| NVSEF | Novartis AG | OTC | Pharmaceuticals | $205.84B | $16.100B | 12.73 | 12.11 | 1.14 | 19.318k | 32.31% | N/A | $114.53 | -0.41% |
| NVS | Novartis AG | NYSE | Pharmaceuticals | $203.64B | $21.982B | 22.56 | 12.65 | 1.14 | 1.156M | 9.20% | 29 Oct 2024 | $115.28 | -1.46% |
| BMY | Bristol-Myers Squibb Co. | NYSE | Pharmaceuticals | $167.61B | $16.796B | N/A | 8.57 | 2.23 | 10.938M | 79.37% | 31 Oct 2024 | $48.59 | -1.40% |
| BRM | Bristol-Myers Squibb Company | XETRA | Pharmaceuticals | $164.82B | $20.383B | 16.32 | 10.17 | 2.04 | 4.308k | 78.19% | N/A | €44.08 | +0.05% |
| AMGN | AMGEN Inc. | NASDAQ | Pharmaceuticals | $153.35B | $11.266B | 56.41 | 20.43 | 14.59 | N/A | 82.11% | 5 Nov 2024 | $329.98 | +0.32% |
| AMG | Amgen, Inc. | XETRA | Pharmaceuticals | $144.23B | 13.178B$ | N/A | 12.95 | 2.24 | 529.000 | 81.50% | N/A | €294.35 | -0.24% |
| SNY | Sanofi | NYSE | Pharmaceuticals | $122.03B | €12.023B | 6.14 | 10.52 | 0.69 | 2.315M | 10.41% | N/A | $57.46 | -1.15% |
| SAN | Sanofi | EURONEXT | Pharmaceuticals | $116.85B | €12.023B | 10.80 | 10.68 | 0.75 | 1.542M | 45.06% | N/A | €103.78 | -0.75% |
| GILD | Gilead Sciences, Inc. | NASDAQ | Pharmaceuticals | $112.22B | $12.178B | 95.22 | 9.78 | 1.72 | N/A | 82.11% | 7 Nov 2024 | $80.94 | -0.61% |
| GIS | Gilead Sciences, Inc. | XETRA | Pharmaceuticals | $107.73B | $12.775B | 43.15 | 9.92 | 2.26 | 1.842k | 82.19% | N/A | €73.32 | +0.97% |
| GS7 | GlaxoSmithKline Plc | XETRA | Pharmaceuticals | $106.14B | £10.817B | 21.44 | 9.90 | 3.61 | 109.617k | 44.16% | N/A | €16.478 | -18.83% |
| GLAXF | GlaxoSmithKline Plc | OTC | Pharmaceuticals | $91.11B | £11.112B | 18.40 | 6.66 | 3.61 | 1.607k | 44.16% | N/A | $21.48 | +0.00% |
| MRK | Merck KGaA | XETRA | Pharmaceuticals | $81.10B | €5.981B | 5.77 | 14.61 | 1.83 | 148.663k | 59.72% | N/A | €171.70 | +1.12% |
| GSK | GlaxoSmithKline Plc | LSE | Pharmaceuticals | $72.57B | £11.112B | 14.66 | 6.67 | 3.61 | 6.942M | 43.35% | N/A | GBX1,657.00 | +0.15% |
| GSK | GSK Plc | NYSE | Pharmaceuticals | $72.52B | £9.049B | 18.63 | 9.28 | 3.42 | N/A | 14.15% | 30 Oct 2024 | $43.77 | -0.75% |
| ZTS | Zoetis Inc | NYSE | Pharmaceuticals | $70.74B | $3.366B | 37.18 | 26.10 | 1.86 | 3.833M | 93.98% | 31 Oct 2024 | $189.99 | -0.72% |
| ZOE | Zoetis Inc. Cl.A Dl ,01 | XETRA | Pharmaceuticals | $68.73B | $3.251B | 36.13 | 22.41 | 2.06 | 133.000 | 93.83% | N/A | €172.42 | +1.27% |
| DSNKY | Daiichi Sankyo Co., Ltd. | OTC | Pharmaceuticals | $61.79B | ¥143.123B | 36.62 | 53.79 | 1.05 | 66.404k | 0.01% | N/A | $37.00 | -0.62% |
| BAYZF | Bayer AG | OTC | Pharmaceuticals | $54.84B | €14.056B | 5.82 | 6.14 | 2.64 | 3.252k | 47.25% | N/A | $31.68 | +0.00% |
| BAYRY | Bayer AG | OTC | Pharmaceuticals | $53.20B | €6.554B | 4.67 | 13.17 | 2.64 | 943.684k | 0.03% | N/A | $7.50 | -1.70% |
| BAYN | Bayer AG | XETRA | Pharmaceuticals | $52.37B | €6.554B | N/A | 12.65 | 2.64 | 2.845M | 47.25% | N/A | €27.075 | +0.24% |
| TKPHF | Takeda Pharmaceutical Co., Ltd. | OTC | Pharmaceuticals | $47.12B | ¥1.030T | 42.67 | 9.96 | 1.08 | 36.561k | 36.77% | N/A | $27.90 | -6.54% |
| TAK | Takeda Pharmaceutical Co | NYSE | Pharmaceuticals | $46.67B | ¥7.075B | 19.25 | 1,575.09 | 1.20 | N/A | 1.89% | 31 Oct 2024 | $14.82 | -0.47% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | OTC | Pharmaceuticals | $41.95B | ¥575.674B | 8.12 | 9.36 | 0.30 | 79.129k | 0.02% | N/A | $23.10 | +0.26% |
| BIIB | Biogen Inc | NASDAQ | Pharmaceuticals | $41.92B | $2.267B | 24.98 | 15.18 | 0.81 | N/A | 87.31% | 6 Nov 2024 | $199.09 | -0.77% |
| IDP | Biogen, Inc. | XETRA | Pharmaceuticals | $40.10B | $3.491B | 7.71 | 12.47 | 1.19 | 386.000 | 87.25% | N/A | €180.80 | +0.90% |
| H6D0 | Haleon Plc Ls 0,01 | XETRA | Pharmaceuticals | $35.34B | N/A | 21.26 | 32.39 | N/A | 23.564k | N/A | N/A | €4.68 | -1.02% |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | NSE | Pharmaceuticals | $30.08B | ₨102.131B | 112.07 | 23.43 | 0.39 | 1.989M | 25.35% | N/A | ₨1,858.60 | +0.70% |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | BSE | Pharmaceuticals | $29.85B | ₨68.779B | 607.18 | 33.15 | 0.42 | 79.476k | 24.28% | N/A | ₨1,864.95 | +1.00% |
| ALPMY | Astellas Pharma, Inc. | OTC | Pharmaceuticals | $28.82B | ¥348.553B | 14.72 | 10.11 | 0.60 | 206.800k | 0.06% | N/A | $12.57 | +0.48% |
| HZNP | Horizon Therapeutics Plc | NASDAQ | Pharmaceuticals | $25.49B | $900.373M | 60.57 | N/A | 1.75 | N/A | 93.75% | N/A | $116.30 | +0.00% |
| ESALY | Eisai Co., Ltd. | OTC | Pharmaceuticals | $20.04B | ¥25.572B | 6.70 | 99.83 | 0.62 | 16.463k | 0.03% | N/A | $61.51 | -2.11% |
| OTSKY | Otsuka Holdings Co., Ltd. | OTC | Pharmaceuticals | $17.94B | ¥219.666B | 29.75 | 9.92 | 0.39 | 28.378k | 0.21% | N/A | $29.05 | +1.50% |
| INDV | Indivior PLC | LSE | Pharmaceuticals | $15.08B | $202.000M | N/A | 11.11 | 33.69 | 881.502k | 67.53% | N/A | GBX742.50 | +3.41% |
| SGIOY | Shionogi & Co., Ltd. | OTC | Pharmaceuticals | $14.92B | ¥113.374B | 1.72 | 13.64 | 0.16 | 153.993k | 0.20% | N/A | $11.39 | +0.18% |
| 2196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | HKSE | Pharmaceuticals | $14.68B | ¥4.839B | 54.15 | 21.50 | 1.00 | 3.436M | 36.33% | N/A | HKD$11.78 | +0.68% |
| VTRS | Viatris Inc. | NASDAQ | Pharmaceuticals | $13.47B | $5.242B | 224.40 | 6.17 | 1.33 | 8.024M | 75.32% | N/A | $11.34 | +1.52% |
| 1093 | CSPC Pharmaceutical Group Limited | HKSE | Pharmaceuticals | $12.92B | ¥7.411B | 14.75 | 10.14 | 0.32 | 50.497M | 33.56% | N/A | HKD$4.55 | +0.00% |
| CIPLA | Cipla Limited | BSE | Pharmaceuticals | $11.25B | ₨31.976B | 89.51 | 26.70 | 0.48 | 42.651k | 34.20% | N/A | ₨1,653.15 | +1.56% |
Sign up
